Predictive Value of Histopathological Variables and Peripheral Immune-Inflammatory Markers in De Novo Metastatic Breast Cancer: Development and Clinical Utility of the Novel KiTNASP Score
Background and Aim: Approximately 10% of breast cancer patients present with distant organ metastases at initial diagnosis. This study aimed to evaluate the efficacy of immune-inflammatory markers and histopathological variables in identifying de novo metastatic breast cancer. Methods: Patients with breast cancer refer...